Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
909,878
-
Shares change
-
+205,889
-
Total reported value, excl. options
-
$911,763
-
Value change
-
+$188,561
-
Number of buys
-
10
-
Number of sells
-
12
-
Price
-
$1.00
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2022
As of 30 Jun 2022 ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) had 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 909,878 shares of stock of the company.
Largest 10 holders included INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, Advisor Resource Council, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CIBC WORLD MARKET INC., ROYAL BANK OF CANADA, Long Focus Capital Management, LLC, TORONTO DOMINION BANK, GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP.
This table shows 43 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.